Clearside Biomedical Announces Plans for ODYSSEY Phase 2b
- Multiple U.S. Clinical Sites to Begin Enrolling ODYSSEY Participants This Quarter - - ODYSSEY Topline Results Expected in Q3 2024 - ALPHARETTA, Ga.,...
George Lasezkay Jenny Kobin Remy Bernarda Exchange Commission Clearside Biomedical Inc Us Food Drug Administration
Source: globenewswire.com